Protect yourself from Coronavirus (COVID-19)

The best way to prevent the ongoing Coronavirus pandemic illness is by avoiding your exposure to the virus. Clean your hands often, use soap and water for at least 20 seconds or a hand sanitizer that contains at least 60% alcohol to clean your hands more frequently.
Avoid touching your eyes, nose and mouth with unwashed hands or after being in the public.
Avoid close contact with people who are sick. Maintain a safe distance between yourself and other people if COVID-19 is spreading in your community.
Stay home if you’re sick and take help from local health authorities and medical professionals.
Make sure to cover your mouth and nose with a tissue or use the inside of your elbow when you cough or sneeze. Properly dispose the used tissues in the trash, and immediately clean your hands with soap and water or a hand sanitizer.
Wear a face mask if you are sick or if you are around other people (e.g., sharing a room or vehicle) and before you enter a healthcare provider’s office. Do not wear a face mask unless you are caring for someone who is sick.

Temple Run game passes 1 Billion downloads across platforms



We hope there won't be any smartphone user, who's not familiar with the Temple Run game. It is one of the hottest endless running game developed and published by the Raleigh-based Imangi Studios, that is available since 2011 for Android, from 2012 on iOS and got introduced to Windows Phone 8 devices last year. The company has officially announced that, they have crossed 1 Billion downloads for both of it's games including, the original Temple Run and the lately outed Temple Run 2, across all the operating systems aforementioned, something like Angry Birds did from Rovio Entertainment.

And for the interesting fact, 60 percent of the game's players are female and it is most popular in China with 36 percent of downloads reporting within the country, where United States stands in the second position with 21 percent downloads, as said by the sources.

Source: The Verge

0 comments: